Clearmind Medicine Inc.

About Clearmind Medicine Inc.

Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental health issues, and other binge behaviors. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada.

Clearmind develops novel psychedelic medicines to solve widespread—yet under-served—health problems. With a strong medical management and IP-protected treatments, we can better the lives of millions.

CMND.CN Canada

7.9USD1.15 (+14.56%)

• At close Thu Oct 06 2022

Canadian Sec exchange

Sector: Healthcare

Industry: Biotechnology

Location Canada, Vancouver

Grade: BDF

146,615,074 USD
BETA (5y)


for 5 years
for 3 years
for 2 years
for last year
for this year
Clearmind Medicine Inc.
© 2023 All rights reserved
Make with 🤎 and ☕ for you!

Investing involves risk, including possible loss of principal.

The strategies discussed are strictly for illustrative and educational purposes and are not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. There is no guarantee that any strategies discussed will be effective.

International investing involves risks, including risks related to foreign currency, limited liquidity, less government regulation and the possibility of substantial volatility due to adverse political, economic or other developments. These risks often are heightened for investments in emerging/ developing markets or in concentrations of single countries.